Dr. Nigel Rawson is a pharmaco-epidemiologist, a pharmaceutical policy researcher, president of Eastlake Research Group and the author of Drug Safety: Problems, Pitfalls and Solutions in Identifying and Evaluating Risk.

Articles by this author

Good governance and decision-making on drug coverage

The federal Minister of Health has initiated an external review of eight pan-Canadian health organizations. One of these is the Canadian Agency for Drugs and Technologies in Health (CADTH), which evaluates and recommends new drugs for insurance coverage within all federal, …

Read More

National pharmacare: equity, equality, affordability?

Proposals for reforming Canada’s public-private drug insurance system have been put forward by academics, politicians and patients over many years. With increased interest in a national pharmacare program expressed in the present federal government’s emphasis …

Read More